Get the Stockscreener App
105.39
0.02%
-0.025
Boston Scientific Corp stock is traded at $105.39, with a volume of 916.98K.
It is down -0.02% in the last 24 hours and up +4.39% over the past month.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
See More
Previous Close:
$105.36
Open:
$104.64
24h Volume:
916.98K
Relative Volume:
0.18
Market Cap:
$155.49B
Revenue:
$16.75B
Net Income/Loss:
$1.85B
P/E Ratio:
84.31
EPS:
1.25
Net Cash Flow:
$2.37B
1W Performance:
-0.73%
1M Performance:
+4.39%
6M Performance:
+33.66%
1Y Performance:
+60.21%
1-Day Range:
$104.42
$105.65
1-Week Range:
$102.92
$105.72
52-Week Range:
$65.52
$107.17
Boston Scientific Corp Stock (BSX) Company Profile
Name
Boston Scientific Corp
Sector
Industry
Phone
508-683-4000
Address
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Compare BSX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
105.44 | 155.49B | 16.75B | 1.85B | 2.37B | 1.25 |
|
ABT
Abbott Laboratories
|
134.57 | 230.98B | 41.95B | 13.40B | 6.49B | 7.65 |
|
SYK
Stryker Corp
|
385.40 | 147.45B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
89.67 | 112.85B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
74.01 | 44.06B | 5.72B | 4.17B | 490.10M | 6.97 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-10-25 | Upgrade | Deutsche Bank | Hold → Buy |
| Oct-18-24 | Downgrade | Needham | Buy → Hold |
| May-30-24 | Initiated | Goldman | Buy |
| Feb-01-24 | Upgrade | Mizuho | Neutral → Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Jun-30-23 | Initiated | CL King | Buy |
| May-30-23 | Resumed | Morgan Stanley | Overweight |
| Mar-29-23 | Initiated | UBS | Buy |
| Dec-22-22 | Initiated | Mizuho | Neutral |
| Dec-20-22 | Resumed | Citigroup | Buy |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-06-22 | Initiated | Wolfe Research | Outperform |
| May-27-22 | Upgrade | Needham | Hold → Buy |
| Apr-13-22 | Resumed | Truist | Buy |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| May-26-21 | Downgrade | Needham | Buy → Hold |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-15-21 | Initiated | Atlantic Equities | Overweight |
| Sep-17-20 | Initiated | Truist | Buy |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| Apr-22-20 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-01-20 | Upgrade | Goldman | Neutral → Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Neutral |
| Feb-06-20 | Resumed | BTIG Research | Buy |
| Dec-30-19 | Reiterated | Cowen | Outperform |
| Dec-19-19 | Downgrade | Needham | Strong Buy → Buy |
| Sep-05-19 | Resumed | JP Morgan | Overweight |
| Sep-03-19 | Resumed | Barclays | Overweight |
| May-13-19 | Upgrade | Evercore ISI | In-line → Outperform |
| Nov-28-18 | Initiated | UBS | Buy |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Oct-02-18 | Reiterated | Morgan Stanley | Overweight |
| Sep-07-18 | Reiterated | Needham | Strong Buy |
| Sep-04-18 | Upgrade | Jefferies | Hold → Buy |
| Jul-06-18 | Reiterated | Needham | Strong Buy |
| Jun-27-18 | Initiated | Bernstein | Outperform |
| Apr-26-18 | Reiterated | Needham | Strong Buy |
View All
Boston Scientific Corp Stock (BSX) Latest News
Boston Scientific hired 5,000 new employees, increased real estate footprint in 2024 - NBC Boston
Boston Scientific ramped up headcount, real estate footprint in 2024 - The Business Journals
$3.77 Bn Surgical Meshes Market Opportunities and Strategies to 2034: Medtronic Leads the Fragmented Market, Followed by Boston Scientific and Johnson & Johnson - GlobeNewswire Inc.
Boston Scientific Co. (NYSE:BSX) CFO Daniel J. Brennan Sells 67,333 Shares - MarketBeat
Boston Sci obtains CE mark for Farapulse navigation mapping system - BioWorld Online
Boston Scientific Co. (NYSE:BSX) EVP Sells $277,417.37 in Stock - MarketBeat
Boston Scientific Expects Strong Gains in 2025: Time to Buy the Stock? - Nasdaq
Boston Scientific Corp. credit rating upgraded to ’A-’ on strong performance: S&P Global - Investing.com Nigeria
Boston Scientific Corp. credit rating upgraded to 'A-' on strong performance: S&P Global - Investing.com
TKG Advisors LLC Purchases 26,005 Shares of Boston Scientific Co. (NYSE:BSX) - MarketBeat
Private Wealth Partners LLC Sells 3,895 Shares of Boston Scientific Co. (NYSE:BSX) - MarketBeat
Venturi Wealth Management LLC Buys 5,821 Shares of Boston Scientific Co. (NYSE:BSX) - MarketBeat
Truist Financial Corp Has $19.28 Million Stake in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific to participate in TD Cowen's 45th Annual Health Care Conference - Quantisnow
Insider Selling: Boston Scientific Co. (NYSE:BSX) EVP Sells 1,201 Shares of Stock - MarketBeat
Congress Asset Management Co. Has $153.83 Million Holdings in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Fitch boosts Boston Scientific's Long-Term IDR to 'A-', maintains stable outlook - Investing.com
Beyond the Balance Sheet: What SWOT Reveals About Boston Scienti - GuruFocus.com
Boston Scientific to participate in TD Cowen's 45th Annual Health Care Conference – Company Announcement - Financial Times
Boston Scientific Co. (NYSE:BSX) Shares Sold by New York State Common Retirement Fund - MarketBeat
Smart Pills Market Deep Research Report with Forecast by 2032 |Boston Scientific Corporation, Olympus Medical - EIN News
Braun Stacey Associates Inc. Lowers Stock Position in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific EVP sells $127,678 in stock By Investing.com - Investing.com Nigeria
Rhumbline Advisers Sells 113,403 Shares of Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific EVP sells $127,678 in stock - Investing.com India
Boston Scientific Corp Files For Debt Shelf, Size Not Disclosed -February 18, 2025 at 05:53 pm EST - Marketscreener.com
Argus Research Adjusts Price Target on Boston Scientific to $130 From $105 -February 18, 2025 at 08:21 am EST - Marketscreener.com
Boston Scientific Co. (NYSE:BSX) Shares Bought by CIBC Asset Management Inc - MarketBeat
Legacy Capital Wealth Partners LLC Takes Position in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific Co. (NYSE:BSX) Shares Sold by Blue Trust Inc. - MarketBeat
Boston Scientific Co. (NYSE:BSX) Shares Purchased by Empowered Funds LLC - MarketBeat
New York State Teachers Retirement System Has $114.79 Million Holdings in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Entropy Technologies LP Makes New $214,000 Investment in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific Co. (NYSE:BSX) Holdings Increased by Avestar Capital LLC - MarketBeat
Boston Scientific Co. (NYSE:BSX) CFO Sells $1,585,191.09 in Stock - MarketBeat
Boston Scientific Co. (NYSE:BSX) Stake Lessened by Chevy Chase Trust Holdings LLC - MarketBeat
Boston Scientific bags CE marking for Farapulse catheter and software - Yahoo Finance
Boston Scientific wins CE mark for Farapulse Nav mapping tech - Mass Device
Edward J. Ludwig Sells 12,000 Shares of Boston Scientific Co. (NYSE:BSX) Stock - MarketBeat
Covenant Asset Management LLC Makes New $3.41 Million Investment in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Bank Pictet & Cie Europe AG Acquires 21,173 Shares of Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific EVP sells shares worth $671,249 - MSN
Allspring Global Investments Holdings LLC Has $182.24 Million Position in Boston Scientific Co. (NYSE:BSX) - MarketBeat
G&S Capital LLC Increases Stake in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific's Jeffrey Mirviss sells $1.37 million in stock - MSN
Boston Scientific director Edward Ludwig sells $1.27 million in stock - MSN
AustralianSuper Pty Ltd Has $231.01 Million Position in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific Co. (NYSE:BSX) Stock Position Decreased by Banque Pictet & Cie SA - MarketBeat
Vontobel Holding Ltd. Has $501.84 Million Stock Holdings in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Louisiana State Employees Retirement System Sells 3,600 Shares of Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific CFO sells $1.59 million in stock - MSN
Boston Scientific Corp Stock (BSX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.20%
1.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):